<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pathogens</journal-id><journal-id journal-id-type="iso-abbrev">Pathogens</journal-id><journal-id journal-id-type="publisher-id">pathogens</journal-id><journal-title-group><journal-title>Pathogens</journal-title></journal-title-group><issn pub-type="epub">2076-0817</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5198159</article-id><article-id pub-id-type="doi">10.3390/pathogens5040059</article-id><article-id pub-id-type="publisher-id">pathogens-05-00059</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Advocating for both Environmental and Clinical Approaches to Control Human Strongyloidiasis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Beknazarova</surname><given-names>Meruyert</given-names></name><xref rid="c1-pathogens-05-00059" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Whiley</surname><given-names>Harriet</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ross</surname><given-names>Kirstin</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Young</surname><given-names>Lawrence</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pathogens-05-00059">School of the Environment, Flinders University, GPO Box 2100, Adelaide 5001, Australia; <email>harriet.whiley@flinders.edu.au</email> (H.W.); <email>kirstin.ross@flinders.edu.au</email> (K.R.)</aff><author-notes><corresp id="c1-pathogens-05-00059"><label>*</label>Correspondence: <email>mira.beknazarova@flinders.edu.au</email>; Tel.: +61-8-7221-8586</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>9</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2016</year></pub-date><volume>5</volume><issue>4</issue><elocation-id>59</elocation-id><history><date date-type="received"><day>09</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>28</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement><copyright-year>2016</copyright-year><license><license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Strongyloidiasis is an underestimated disease caused by the soil-transmitted parasite of the genus <italic>Strongyloides</italic>. It is prevalent in socioeconomically disadvantaged communities and it is estimated that global infection could be as high as 370 million people. This paper explores current methods of strongyloidiasis treatment, which rely on administration of anthelminthic drugs. However these drugs cannot prevent reinfection and drug resistance has already been observed in veterinary models. This highlights the need for a combined approach for controlling <italic>Strongyloides</italic> that includes both clinical treatment and environmental control methods. Currently, nematicides are widely used to control plant parasites. The review suggests that due to the species&#x02019; similarity and similar modes of action, these nematicides could also be used to control animal and human parasitic nematodes in the environment.</p></abstract><kwd-group><kwd>strongyloidiasis</kwd><kwd><italic>Strongyloides stercoralis</italic></kwd><kwd>anthelminthic drugs</kwd><kwd>nematicides</kwd><kwd>ivermectin</kwd><kwd>resistance</kwd></kwd-group></article-meta></front><body><sec id="sec1-pathogens-05-00059"><title>1. Introduction</title><p>Strongyloidiasis is a disease caused by two soil-transmitted helminths of the genus <italic>Strongyloides</italic>, <italic>Strongyloides stercoralis</italic> and to a lesser extent <italic>Strongyloides fuelleborni</italic>. <italic>S. fuelleborni</italic> is only found in Africa and the Southeast Asian countries of Papua New Guinea, while <italic>S. stercoralis</italic> is globally distributed and is clinically more important [<xref rid="B1-pathogens-05-00059" ref-type="bibr">1</xref>,<xref rid="B2-pathogens-05-00059" ref-type="bibr">2</xref>]. Strongyloidiasis is an underestimated disease highly prevalent in socioeconomic disadvantage communities [<xref rid="B3-pathogens-05-00059" ref-type="bibr">3</xref>,<xref rid="B4-pathogens-05-00059" ref-type="bibr">4</xref>]. Although it is currently estimated that about 30&#x02013;100 million people are infected globally, a more accurate estimate is thought to be around 300 million [<xref rid="B2-pathogens-05-00059" ref-type="bibr">2</xref>,<xref rid="B5-pathogens-05-00059" ref-type="bibr">5</xref>] or up to 370 million people [<xref rid="B6-pathogens-05-00059" ref-type="bibr">6</xref>]. Due to the ability of <italic>S. stercoralis</italic> to remain in a host organism as autoinfective filariform larvae (L3), a person can stay asymptomatically infected for decades [<xref rid="B7-pathogens-05-00059" ref-type="bibr">7</xref>,<xref rid="B8-pathogens-05-00059" ref-type="bibr">8</xref>]. Parthenogenesis allows a single remaining female parasite present in a host to reproduce and cause reinfection, which has serious ramifications for effective treatment [<xref rid="B1-pathogens-05-00059" ref-type="bibr">1</xref>,<xref rid="B9-pathogens-05-00059" ref-type="bibr">9</xref>,<xref rid="B10-pathogens-05-00059" ref-type="bibr">10</xref>]. The survival of asexually produced infective larvae (L3) is estimated to be less than 14 days. However, heterogonically developed infective larvae (L3) have been shown to survive indefinitely in the soil of optimal environment conditions until they find a host [<xref rid="B9-pathogens-05-00059" ref-type="bibr">9</xref>,<xref rid="B11-pathogens-05-00059" ref-type="bibr">11</xref>,<xref rid="B12-pathogens-05-00059" ref-type="bibr">12</xref>]. The complicated <italic>S. stercoralis</italic> life-cycle, insensitivity of detection methods and social factors challenge strongyloidiasis identification, diagnosis and treatment [<xref rid="B3-pathogens-05-00059" ref-type="bibr">3</xref>,<xref rid="B13-pathogens-05-00059" ref-type="bibr">13</xref>]. If not diagnosed in time it can lead to fatal outcomes [<xref rid="B1-pathogens-05-00059" ref-type="bibr">1</xref>,<xref rid="B14-pathogens-05-00059" ref-type="bibr">14</xref>], and given that we see high disease rates in population sub-groups, strongyloidiasis is not only a personal but a public health issue [<xref rid="B2-pathogens-05-00059" ref-type="bibr">2</xref>,<xref rid="B15-pathogens-05-00059" ref-type="bibr">15</xref>].</p><p><italic>Strongyloides</italic> genus species have both parasitic and free-living life cycles. The infection of a human starts from infective larvae (filariform larvae L3), which penetrate the host and are transported via blood to the lungs, from where the larvae migrate to the gastrointestinal tract. In the intestine, larvae moult two times to become adult female worms, which hatch eggs through parthenogenesis and produce rhabditiform larvae. The rhabditiform larvae can either be excreted in feces or become infective filariform larvae autoinfecting a host [<xref rid="B7-pathogens-05-00059" ref-type="bibr">7</xref>]. Certain respiratory conditions; however, are believed to affect the filariform larvae transition through the lungs and cause its development into adult egg laying female worms in the lungs [<xref rid="B16-pathogens-05-00059" ref-type="bibr">16</xref>,<xref rid="B17-pathogens-05-00059" ref-type="bibr">17</xref>]. The repeated cycle of this leads to pulmonary strongyloidiasis [<xref rid="B18-pathogens-05-00059" ref-type="bibr">18</xref>]. There are no further studies done showing the filariform larvae maturing into adult worm in the lungs. The pulmonary strongyloidiasis is believed to occur due to autoinfection and filariform larvae disseminating to respiratory system [<xref rid="B19-pathogens-05-00059" ref-type="bibr">19</xref>]. Currently, the nematode&#x02019;s environmental stage has not been extensively studied or controlled. However, exploring mechanisms to control the nematode in the environment should be made a priority. Biocontrol has been described as a promising way of environmental control of agricultural, animal and human soil-transmitted nematodes [<xref rid="B20-pathogens-05-00059" ref-type="bibr">20</xref>], and the use of commercially available nematicides should be considered and explored. </p><p>At the World Health Organization global parasite control meeting in 2004 it was recommended that <italic>S. stercoralis</italic> control measures should be included in the health package for endemic areas [<xref rid="B21-pathogens-05-00059" ref-type="bibr">21</xref>]. However, to date, there has been no progress made mostly due to the gaps in knowledge regarding <italic>S. stercoralis</italic> treatment and control [<xref rid="B22-pathogens-05-00059" ref-type="bibr">22</xref>]. Investigation into transmission hot-spots is currently being undertaken [<xref rid="B23-pathogens-05-00059" ref-type="bibr">23</xref>]. To address the transmission, the best management approaches need to be identified and this discussion represents a step in this process. For example, wastewater overflow in septic tanks, solid waste including diapers or other animal feces might be areas to target.</p><p>This paper reviews currently commercially available drugs used to treat human strongyloidiasis, and explores the main issues associated with drug application. In addition, this paper looks at nematicides registered in Australia, their use, main constituents, mode of action and toxic effects. To date, strongyloidiasis treatment has tended to be viewed only from a clinical perspective, which is an inevitable part of treatment once infection has occurred. However, drug treatment cannot prevent reinfection and there is the potential for drug resistance. Here we suggest a combined approach of strongyloidiasis treatment; through clinical intervention with drugs once infection has occurred, but supplemented with nematode control in the environment. The advantages and concerns with both approaches are discussed.</p></sec><sec id="sec2-pathogens-05-00059"><title>2. Anthelminthic Drugs</title><p>The World Health Organization currently recommends albendazole and ivermectin as suitable drugs against strongyloidiasis. Mebendazole is not recommended anymore, as it has been demonstrated to have a suboptimal effect against strongyloidiasis (<xref ref-type="table" rid="pathogens-05-00059-t001">Table 1</xref>) [<xref rid="B24-pathogens-05-00059" ref-type="bibr">24</xref>]. Ivermectin has been shown to be the most effective and therefore the first choice drug in strongyloidiasis treatment [<xref rid="B25-pathogens-05-00059" ref-type="bibr">25</xref>], especially for chronic strongyloidiasis [<xref rid="B26-pathogens-05-00059" ref-type="bibr">26</xref>,<xref rid="B27-pathogens-05-00059" ref-type="bibr">27</xref>].</p><sec id="sec2dot1-pathogens-05-00059"><title>2.1. Benzimidazoles (Albendazole and Mebendazole)</title><p>Benzimidazole is a group of anthelminthic drugs, which includes albendazole and mebendazole. They are shown to affect parasite locomotion and reproduction through action on the &#x003b2;-tubulin, compromising nematode&#x02019;s cytoskeleton by impairing glucose uptake [<xref rid="B33-pathogens-05-00059" ref-type="bibr">33</xref>]. Albendazole is poorly absorbed and a single dose is shown to have an efficacy rate of 62.2% [<xref rid="B33-pathogens-05-00059" ref-type="bibr">33</xref>,<xref rid="B34-pathogens-05-00059" ref-type="bibr">34</xref>]. </p></sec><sec id="sec2dot2-pathogens-05-00059"><title>2.2. Macrocyclic Lactones (Ivermectin)</title><p>Macrocyclic lactones (MLs), in which ivermectin is the only approved drug for use in humans, act on nematodes residing in mammals&#x02019; gastrointestinal tract or lungs, inhibiting their capacity to move and feed, which results in their death [<xref rid="B35-pathogens-05-00059" ref-type="bibr">35</xref>]. Ivermectin is a very effective drug against early and adult stages of gastrointestinal parasites, and less effective against adult stages of filarial nematodes [<xref rid="B35-pathogens-05-00059" ref-type="bibr">35</xref>]. Macrocyclic lactones including ivermectin are known to react with a range of ligand-gated ion channels (&#x003b1;7 nACh receptors, acetylcholine-gated chloride channels, GABA-gated chloride channels, histamine-gated chloride channels, glycine receptors, and P2X4 receptors). The anthelminthic activity is shown by ivermectin interacting with glutamate-gated chloride channels (GluCl) in nematodes, increasing chloride permeability, which results in nematode paralysis [<xref rid="B36-pathogens-05-00059" ref-type="bibr">36</xref>,<xref rid="B37-pathogens-05-00059" ref-type="bibr">37</xref>]. Ivermectin is currently the best treatment for onchocerciasis and administered at intervals of one year in highly prevalent countries. While it is also effective at treating other helminth infections, it is not available in the onchocerciasis-free areas and recommended to be substituted with diethylcarbamazine [<xref rid="B24-pathogens-05-00059" ref-type="bibr">24</xref>,<xref rid="B38-pathogens-05-00059" ref-type="bibr">38</xref>]. Due to the strong protein binding ability of ivermectin, its oral administration can be impaired in strongyloidiasis disseminated patients. There is, however, no parenteral administration of ivermectin licensed currently, which is essential in cases of disseminated strongyloidiasis [<xref rid="B39-pathogens-05-00059" ref-type="bibr">39</xref>,<xref rid="B40-pathogens-05-00059" ref-type="bibr">40</xref>].</p></sec><sec id="sec2dot3-pathogens-05-00059"><title>2.3. Anthelminthic Drugs Associated Issues</title><p>Treatment of soil-transmitted helminthiasis is challenging due to development of resistance, as demonstrated in veterinary practice, and reinfection occurrence [<xref rid="B41-pathogens-05-00059" ref-type="bibr">41</xref>,<xref rid="B42-pathogens-05-00059" ref-type="bibr">42</xref>]. Among soil-transmitted helminth infections, strongyloidiasis is the most difficult to treat because of its unique ability of autoinfection, especially in cases of hyperinfection or disseminated diseases [<xref rid="B1-pathogens-05-00059" ref-type="bibr">1</xref>,<xref rid="B2-pathogens-05-00059" ref-type="bibr">2</xref>,<xref rid="B25-pathogens-05-00059" ref-type="bibr">25</xref>,<xref rid="B31-pathogens-05-00059" ref-type="bibr">31</xref>,<xref rid="B43-pathogens-05-00059" ref-type="bibr">43</xref>]. The drug treatment efficacy depends also on number of factors including an individual&#x02019;s immune system, co-infection with HTLV-1 and history of drug intake [<xref rid="B44-pathogens-05-00059" ref-type="bibr">44</xref>,<xref rid="B45-pathogens-05-00059" ref-type="bibr">45</xref>,<xref rid="B46-pathogens-05-00059" ref-type="bibr">46</xref>,<xref rid="B47-pathogens-05-00059" ref-type="bibr">47</xref>]. Fecal examination, traditionally used for monitoring treatment efficacy, is associated with low sensitivity. Although less available in low resource settings, serology tests are known for higher sensitivity and accuracy, and should be used for not only strongyloidiasis diagnosis but also follow-up tests [<xref rid="B48-pathogens-05-00059" ref-type="bibr">48</xref>,<xref rid="B49-pathogens-05-00059" ref-type="bibr">49</xref>].</p><p>The drugs, while reasonably well tolerated, can cause adverse effects including liver disfunction, gastrointestinal symptoms (nausea, vomiting, loose stool, abdominal distension or pain), chest tightness or pain, itching, fever, cough and wheezing, dizziness, and neurological effects [<xref rid="B50-pathogens-05-00059" ref-type="bibr">50</xref>,<xref rid="B51-pathogens-05-00059" ref-type="bibr">51</xref>,<xref rid="B52-pathogens-05-00059" ref-type="bibr">52</xref>,<xref rid="B53-pathogens-05-00059" ref-type="bibr">53</xref>]. Another issue with anthelminthic drugs is their teratogenicity potential in pregnant women who have a high risk of developing iron-deficiency anemia [<xref rid="B54-pathogens-05-00059" ref-type="bibr">54</xref>]. </p><p>Animal-infecting nematode resistance development results in need for new anthelminthic drugs to be introduced to the market. Nematode resistance to different drugs has been widely studied and demonstrated frequently in animal studies [<xref rid="B31-pathogens-05-00059" ref-type="bibr">31</xref>,<xref rid="B41-pathogens-05-00059" ref-type="bibr">41</xref>,<xref rid="B42-pathogens-05-00059" ref-type="bibr">42</xref>,<xref rid="B55-pathogens-05-00059" ref-type="bibr">55</xref>,<xref rid="B56-pathogens-05-00059" ref-type="bibr">56</xref>,<xref rid="B57-pathogens-05-00059" ref-type="bibr">57</xref>,<xref rid="B58-pathogens-05-00059" ref-type="bibr">58</xref>]. Resistance to the benzimidazole class of drugs has been shown to be up to 97.7% and 71% in gastrointestinal nematodes parasitizing horse and sheep respectively [<xref rid="B28-pathogens-05-00059" ref-type="bibr">28</xref>,<xref rid="B29-pathogens-05-00059" ref-type="bibr">29</xref>]. Resistance (66.7%) to benzimidazoles has been also determined in sheep <italic>Strongyloides</italic> spp. [<xref rid="B30-pathogens-05-00059" ref-type="bibr">30</xref>]. The most recently introduced anthelminthic drug, ivermectin, has been shown to be the most successful in helminth infection treatment with less resistance development compared with the benzimidazole drugs. Nevertheless, resistance has been demonstrated in the last few years in gastrointestinal nematodes (29%), and sheep <italic>Strongyloides</italic> spp. (40%) [<xref rid="B29-pathogens-05-00059" ref-type="bibr">29</xref>]. Treatment of sheep parasites two times per year caused a rapid drug resistance development demonstrating that resistance can occur even in low frequency drug application [<xref rid="B59-pathogens-05-00059" ref-type="bibr">59</xref>]. This suggests that human-infecting nematodes are also likely, at some stage in the future, to become resistant to the available drugs. This is also induced by continuous use of a one drug family over the years, as in case of ivermectin against strongyloidiasis [<xref rid="B60-pathogens-05-00059" ref-type="bibr">60</xref>]. Studies on benzimidazole drugs against human nematodes have reported low efficacy of drug treatment, calling for great attention and warning for possible resistance development [<xref rid="B61-pathogens-05-00059" ref-type="bibr">61</xref>,<xref rid="B62-pathogens-05-00059" ref-type="bibr">62</xref>]. To date, human nematode studies with ivermectin have shown no resistance to the drug [<xref rid="B50-pathogens-05-00059" ref-type="bibr">50</xref>].</p><p>A little is understood in the mechanism of resistance development in <italic>S. stercoralis</italic> or other human parasites to anthelminthic drugs. Satoh et al. (1999) have found that <italic>S. stercoralis</italic> specific antibody, IgG4, is associated with both resistance to albendazole and elevated level of HLA-DRBI*0901, suggesting that patients should be tested for this antibody prior to drug treatment to check for their therapeutic effect on them. However, no other reports are available showing the association between increased level of IgG4 and resistance in a parasite [<xref rid="B60-pathogens-05-00059" ref-type="bibr">60</xref>]. A human immune system changes in response to strongyloidiasis infection, in particular T and B cells. The immune system has two responses to infective filariform larvae and host adapted larvae, which start autoinfection [<xref rid="B44-pathogens-05-00059" ref-type="bibr">44</xref>]. There are two mechanisms of ivermectin resistance identified so far: alteration of the membrane transport protein called P-glycoprotein, which is responsible for the drug delivery to the cell membrane, and alteration of the Cl channel receptor [<xref rid="B58-pathogens-05-00059" ref-type="bibr">58</xref>,<xref rid="B63-pathogens-05-00059" ref-type="bibr">63</xref>,<xref rid="B64-pathogens-05-00059" ref-type="bibr">64</xref>,<xref rid="B65-pathogens-05-00059" ref-type="bibr">65</xref>].</p><p>It is a risk for resistance development in response to large scale drug administration programs within the parasite control programs. The presence of a free-living stage of <italic>S. stercoralis</italic>, sexual reproduction, and relatively short lifespan and generation time could contribute to quicker drug resistance development in nematodes. Generally it is thought that if different drugs target and involve different receptors, their combined use will delay resistance development [<xref rid="B66-pathogens-05-00059" ref-type="bibr">66</xref>]. However, if resistance in two drugs involves same mechanism, combined drug treatment may be overlooked. ABC transporters have been shown to be involved in both ivermectin and albendazole resistance, which can potentially enhance the resistance development if both drugs are used for treatment [<xref rid="B64-pathogens-05-00059" ref-type="bibr">64</xref>]. It has been shown in some nematodes that ivermectin selects on &#x003b2;-tubulin, which is a primarily receptor for albendazole [<xref rid="B66-pathogens-05-00059" ref-type="bibr">66</xref>]. </p><p>Although it is more difficult to study and confirm anthelminthic resistance in human parasites due to number of factors, the potential for resistance is mostly overlooked and should be more carefully examined in drug treatment application [<xref rid="B67-pathogens-05-00059" ref-type="bibr">67</xref>]. Notably, there are many gaps identified in our understanding of the pharmacology of anthelminthic drugs despite the fact that that millions of people around the world are treated by these drugs [<xref rid="B35-pathogens-05-00059" ref-type="bibr">35</xref>]. </p><p>Mass drug administration (MDA) is the main clinical approach to controlling highly prevalent neglected tropical diseases. Ivermectin, along with benzimidazole drugs, have been shown to be effective against intestinal helminth and schistosome infections. Coadministration of different anthelminthic drugs allows integrating control programs for intestinal helminth infections, lymphatic filariasis and onchocerciasis with schistosomiasis and food-borne trematode infections. However, MDA could be associated with a higher risk for resistance development, as more people are given the drug more often, including those that are no carrying disease. More research is required to study the long-term effects of repeated drug doses [<xref rid="B38-pathogens-05-00059" ref-type="bibr">38</xref>,<xref rid="B68-pathogens-05-00059" ref-type="bibr">68</xref>].</p></sec></sec><sec id="sec3-pathogens-05-00059"><title>3. Nematicides</title><p>Nematicides are used to control plant parasite nematodes, which are ubiquitous and globally cause costly yield loses in agriculture [<xref rid="B32-pathogens-05-00059" ref-type="bibr">32</xref>,<xref rid="B69-pathogens-05-00059" ref-type="bibr">69</xref>]. To date, there have been limited studies demonstrating nematicides use on non-plant nematodes, as they are mostly treated by anthelminthic drugs. However, the mode of their action and species&#x02019; similarity might allow using them on animal and human parasites. </p><p>According to the Australian Pesticides and Veterinary Medicines Authority there are currently around 20 registered nematicides to use in Australia with the four active compounds fenamiphos, fluensulfone, oxamyl and carbofuran (<xref ref-type="table" rid="pathogens-05-00059-t002">Table 2</xref>) [<xref rid="B70-pathogens-05-00059" ref-type="bibr">70</xref>]. The active constituents of used nematicides are of organophosphorus, carbamate and thiazole chemical groups.</p><sec id="sec3dot1-pathogens-05-00059"><title>3.1. Organophosphorus and Carbamate Nematicides (Fenamiphos, Oxamyl and Carbofuran) Mode of Action</title><p>Organophosphates and carbamates are non-fumigant nematicides. Organophosphorus and carbamate nematicides (fenamiphos, oxamyl and carbofuran) cause the paralysis of nematodes through inhibition of cholinesterase enzymes, which are responsible for acetylcholine neurotransmitter breakdown. Organophosphates and carbamates cause either irreversible or reversible inhibition of a cholinesterase enzyme blocking its function [<xref rid="B71-pathogens-05-00059" ref-type="bibr">71</xref>].</p><p>Not much research has been done on human parasitic nematodes including <italic>S. stercoralis</italic>; however, in <italic>C. elegans</italic>, acetylcholine is the neurotransmitter that controls nematode&#x02019;s movement, pharyngeal pumping, and egg laying. When acetylcholinesterase/cholinesterase suppressed, acetylcholine builds up, transmitting nerve impulses and causing constant muscle and nerve contraction leading to the nematode&#x02019;s exhaustion and tetany [<xref rid="B72-pathogens-05-00059" ref-type="bibr">72</xref>]. Oxamyl is known as a more effective nematicide than fenamiphos [<xref rid="B73-pathogens-05-00059" ref-type="bibr">73</xref>].</p></sec><sec id="sec3dot2-pathogens-05-00059"><title>3.2. Thiazole (Fluensulfone) Mode of Action</title><p>Fluensulfone, a fluoroalkenyl thioether group drug, has different mode of action and effect on nematodes from those of organophosphorus and carbamate nematicides and also anthelminthic drugs such as ivermectin [<xref rid="B74-pathogens-05-00059" ref-type="bibr">74</xref>]. There have not been studies done describing its mode of action on nematodes. However, fluensulfone has shown to be highly effective against a number of plant nematodes [<xref rid="B18-pathogens-05-00059" ref-type="bibr">18</xref>,<xref rid="B74-pathogens-05-00059" ref-type="bibr">74</xref>]. In their study, Kearn et al. (2014) have studied fluensulfone effect on <italic>C. elegans</italic>, a genetic nematode model to study effects of different anthelminthic drugs and nematicides that are used against animal and human parasites [<xref rid="B32-pathogens-05-00059" ref-type="bibr">32</xref>]. It has been shown that a slightly higher dose of fluensulfone is required to have a similar effect on <italic>C. elegans</italic> as on plant parasite nematodes, inhibiting egg laying, hatching, development, feeding and moving stages of the nematode [<xref rid="B74-pathogens-05-00059" ref-type="bibr">74</xref>]. </p></sec><sec id="sec3dot3-pathogens-05-00059"><title>3.3. Nematicides Associated Issues (Toxic Effects and Resistance to Nematicides)</title><p>Most cholinesterase inhibiting nematicides have been banned or restricted for use due to their adverse toxic effects on non-target organisms including humans, and the environment, which is associated with absence of species&#x02019; selectivity [<xref rid="B32-pathogens-05-00059" ref-type="bibr">32</xref>,<xref rid="B71-pathogens-05-00059" ref-type="bibr">71</xref>]. Another disadvantage of non-fumigant nematicides is their mobility in soil which can potentially cause widespread non-target toxic effects. Oxamyl and fenamiphos are known for leaching from the site of application [<xref rid="B75-pathogens-05-00059" ref-type="bibr">75</xref>,<xref rid="B76-pathogens-05-00059" ref-type="bibr">76</xref>]. Carbofuran has been banned for use in European Union in 2009 (Regulation 1107/2009), Canada and U.S. due to its adverse side-effects [<xref rid="B77-pathogens-05-00059" ref-type="bibr">77</xref>].</p><p>A study on fenamiphos, oxamyl and carbofuran effects on <italic>C. elegans</italic> has shown AChE recovery ability by nematodes in response to all the three nematicides. It has been also shown that only small recovery of the enzyme is required for nematode moving restoration and normal behaviour [<xref rid="B78-pathogens-05-00059" ref-type="bibr">78</xref>].</p><p>There are currently no studies available on the non-specific toxicity of fluensulfone. However, the acute LD<sub>50</sub> value for rats via for oral administration of fluensulfone is much lower compared with organophosphate nematicides [<xref rid="B18-pathogens-05-00059" ref-type="bibr">18</xref>,<xref rid="B79-pathogens-05-00059" ref-type="bibr">79</xref>]. </p><p>It is commonly thought that nematicide resistance for plant nematodes is not as great a concern as for animal nematodes, hence there are limited studies exploring potential plant nematodes&#x02019; resistance compared to the numerous studies on animal nematodes&#x02019; resistance. It is thought that there is a lesser potential for the development of plant nematicide resistance due to number of factors. These include: nematicides altering the selection pressure on plant parasitic nematodes, mitotic parthenogenesis in plant nematodes leading to less genetic diversity, and biodegradation of nematicides by soil bacteria [<xref rid="B80-pathogens-05-00059" ref-type="bibr">80</xref>]. However, these factors can probably delay but not prevent resistance development. It is known that resistance is more likely to develop with persistent compounds such as organophosphorus and carbamate substances rather than short-lived molecules [<xref rid="B81-pathogens-05-00059" ref-type="bibr">81</xref>]. Plant nematodes have been shown to be quite adaptive to chemical treatment. <italic>Rhabditis oxycerca, Criconemella xenoplax, Xiphinema index, Meloidogyne incognita and Pratylenchus vulnus</italic> have developed high resistance to organophosphates and carbomates after long-term exposure [<xref rid="B82-pathogens-05-00059" ref-type="bibr">82</xref>,<xref rid="B83-pathogens-05-00059" ref-type="bibr">83</xref>].</p></sec></sec><sec id="sec4-pathogens-05-00059"><title>4. Conclusions</title><p>While nematicides are extensively used against plant nematodes, their use is limited or non-existent in human parasite control. An overlooked environmental approach in strongyloidiasis control is to kill free-living parasites in environment before they get into a human host.</p><p>Above we have assessed commercially available drugs used to treat strongyloidiasis and explored the main issues associated with these drug treatments. This includes the emergence of drug resistance in numerous animal nematodes when applied in veterinary practice. This highlights the potential for resistance in human helminths, which is a particular problem for <italic>S. stercoralis</italic> as currently there is only two drugs approved for human treatment. Other issues with treatment include drugs&#x02019; inability to prevent reinfection, and potential for problems associated with drug administration during pregnancy. Nematicides have potential to be used on free-living <italic>Strongyloides</italic> nematodes. A combined approach to fight strongyloidiasis should consider environmental control as well as drug treatment. Future studies could consider focusing initial efforts on the nematicide fluensulfone, which has been shown to have the least toxic effect on the environment and non-target species, and desirable effects on all the stages of a nematode, as demonstrated by a model parasite, <italic>C. elegans</italic>.</p></sec></body><back><ack><title>Acknowledgments</title><p>We have received no funds to publish in open access.</p></ack><notes><title>Author Contributions</title><p>Meruyert Beknazarova, Harriet Whiley and Kirstin Ross conceived and participated in review design and coordination. Meruyert Beknazarova drafted manuscript, and Harriet Whiley and Kirstin Ross provided academic input and all authors approved the final manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-pathogens-05-00059"><label>1.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grove</surname><given-names>D.I.</given-names></name></person-group>
<article-title>Human strongyloidiasis</article-title>
<source>Adv. Parasitol.</source>
<year>1995</year>
<volume>38</volume>
<fpage>251</fpage>
<lpage>309</lpage>
</element-citation></ref><ref id="B2-pathogens-05-00059"><label>2.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olsen</surname><given-names>A.</given-names></name><name><surname>van Lieshout</surname><given-names>L.</given-names></name><name><surname>Marti</surname><given-names>H.</given-names></name><name><surname>Polderman</surname><given-names>T.</given-names></name><name><surname>Polman</surname><given-names>K.</given-names></name><name><surname>Steinmann</surname><given-names>P.</given-names></name><name><surname>Stothard</surname><given-names>R.</given-names></name><name><surname>Thybo</surname><given-names>S.</given-names></name><name><surname>Verweij</surname><given-names>J.J.</given-names></name><name><surname>Magnussen</surname><given-names>P.</given-names></name></person-group>
<article-title>Strongyloidiasis&#x02013;the most neglected of the neglected tropical diseases?</article-title>
<source>Trans. R. Soc. Trop. Med. Hyg.</source>
<year>2009</year>
<volume>103</volume>
<fpage>967</fpage>
<lpage>972</lpage>
<pub-id pub-id-type="doi">10.1016/j.trstmh.2009.02.013</pub-id>
<?supplied-pmid 19328508?><pub-id pub-id-type="pmid">19328508</pub-id></element-citation></ref><ref id="B3-pathogens-05-00059"><label>3.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beknazarova</surname><given-names>M.</given-names></name><name><surname>Whiley</surname><given-names>H.</given-names></name><name><surname>Ross</surname><given-names>K.</given-names></name></person-group>
<article-title>Strongyloidiasis: A disease of socioeconomic disadvantage</article-title>
<source>Int. J. Environ. Res. Public Health</source>
<year>2016</year>
<volume>13</volume>
<fpage>517</fpage>
<pub-id pub-id-type="doi">10.3390/ijerph13050517</pub-id>
<?supplied-pmid 27213420?><pub-id pub-id-type="pmid">27213420</pub-id></element-citation></ref><ref id="B4-pathogens-05-00059"><label>4.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sch&#x000e4;r</surname><given-names>F.</given-names></name><name><surname>Trostdorf</surname><given-names>U.</given-names></name><name><surname>Giardina</surname><given-names>F.</given-names></name><name><surname>Khieu</surname><given-names>V.</given-names></name><name><surname>Muth</surname><given-names>S.</given-names></name><name><surname>Marti</surname><given-names>H.</given-names></name><name><surname>Vounatsou</surname><given-names>P.</given-names></name><name><surname>Odermatt</surname><given-names>P.</given-names></name></person-group>
<article-title>Strongyloides stercoralis: Global distribution and risk factors</article-title>
<source>PLoS Negl. Trop. Dis.</source>
<year>2013</year>
<volume>7</volume>
<elocation-id>e2288</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0002288</pub-id>
<?supplied-pmid 23875033?><pub-id pub-id-type="pmid">23875033</pub-id></element-citation></ref><ref id="B5-pathogens-05-00059"><label>5.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bethony</surname><given-names>J.</given-names></name><name><surname>Brooker</surname><given-names>S.</given-names></name><name><surname>Albonico</surname><given-names>M.</given-names></name><name><surname>Geiger</surname><given-names>S.M.</given-names></name><name><surname>Loukas</surname><given-names>A.</given-names></name><name><surname>Diemert</surname><given-names>D.</given-names></name><name><surname>Hotez</surname><given-names>P.J.</given-names></name></person-group>
<article-title>Soil-transmitted helminth infections: Ascariasis, trichuriasis, and hookworm</article-title>
<source>Lancet</source>
<year>2006</year>
<volume>367</volume>
<fpage>1521</fpage>
<lpage>1532</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(06)68653-4</pub-id>
<pub-id pub-id-type="pmid">16679166</pub-id></element-citation></ref><ref id="B6-pathogens-05-00059"><label>6.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bisoffi</surname><given-names>Z.</given-names></name><name><surname>Buonfrate</surname><given-names>D.</given-names></name><name><surname>Montresor</surname><given-names>A.</given-names></name><name><surname>Requena-M&#x000e9;ndez</surname><given-names>A.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>J.</given-names></name><name><surname>Krolewiecki</surname><given-names>A.J.</given-names></name><name><surname>Gotuzzo</surname><given-names>E.</given-names></name><name><surname>Mena</surname><given-names>M.A.</given-names></name><name><surname>Chiodini</surname><given-names>P.L.</given-names></name><name><surname>Anselmi</surname><given-names>M.</given-names></name></person-group>
<article-title>Strongyloides stercoralis: A plea for action</article-title>
<source>PLoS Negl. Trop. Dis.</source>
<year>2013</year>
<volume>7</volume>
<elocation-id>e2214</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0002214</pub-id>
<?supplied-pmid 23675546?><pub-id pub-id-type="pmid">23675546</pub-id></element-citation></ref><ref id="B7-pathogens-05-00059"><label>7.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lim</surname><given-names>S.</given-names></name><name><surname>Katz</surname><given-names>K.</given-names></name><name><surname>Krajden</surname><given-names>S.</given-names></name><name><surname>Fuksa</surname><given-names>M.</given-names></name><name><surname>Keystone</surname><given-names>J.S.</given-names></name><name><surname>Kain</surname><given-names>K.C.</given-names></name></person-group>
<article-title>Complicated and fatal strongyloides infection in canadians: Risk factors, diagnosis and management</article-title>
<source>Can. Med. Assoc. J.</source>
<year>2004</year>
<volume>171</volume>
<fpage>479</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="doi">10.1503/cmaj.1031698</pub-id>
<?supplied-pmid 15337730?><pub-id pub-id-type="pmid">15337730</pub-id></element-citation></ref><ref id="B8-pathogens-05-00059"><label>8.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ericsson</surname><given-names>C.D.</given-names></name><name><surname>Steffen</surname><given-names>R.</given-names></name><name><surname>Siddiqui</surname><given-names>A.A.</given-names></name><name><surname>Berk</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Diagnosis of strongyloides stercoralis infection</article-title>
<source>Clin. Infect. Dis.</source>
<year>2001</year>
<volume>33</volume>
<fpage>1040</fpage>
<lpage>1047</lpage>
<pub-id pub-id-type="pmid">11528578</pub-id></element-citation></ref><ref id="B9-pathogens-05-00059"><label>9.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Streit</surname><given-names>A.</given-names></name></person-group>
<article-title>Reproduction in strongyloides (nematoda): A life between sex and parthenogenesis</article-title>
<source>Parasitology</source>
<year>2008</year>
<volume>135</volume>
<fpage>285</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1017/S003118200700399X</pub-id>
<?supplied-pmid 18076772?><pub-id pub-id-type="pmid">18076772</pub-id></element-citation></ref><ref id="B10-pathogens-05-00059"><label>10.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keiser</surname><given-names>P.B.</given-names></name><name><surname>Nutman</surname><given-names>T.B.</given-names></name></person-group>
<article-title>Strongyloides stercoralis in the immunocompromised population</article-title>
<source>Clin. Microbiol. Rev.</source>
<year>2004</year>
<volume>17</volume>
<fpage>208</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.17.1.208-217.2004</pub-id>
<?supplied-pmid 14726461?><pub-id pub-id-type="pmid">14726461</pub-id></element-citation></ref><ref id="B11-pathogens-05-00059"><label>11.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Grove</surname><given-names>D.I.</given-names></name></person-group>
<source>Strongyloidiasis: A Major Roundworm Infection of Man</source>
<publisher-name>Taylor and Francis Ltd.</publisher-name>
<publisher-loc>London, UK</publisher-loc>
<year>1989</year>
</element-citation></ref><ref id="B12-pathogens-05-00059"><label>12.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toledo</surname><given-names>R.</given-names></name><name><surname>Mu&#x000f1;oz-Antoli</surname><given-names>C.</given-names></name><name><surname>Esteban</surname><given-names>J.-G.</given-names></name></person-group>
<article-title>Chapter five-strongyloidiasis with emphasis on human infections and its different clinical forms</article-title>
<source>Adv. Parasitol.</source>
<year>2015</year>
<volume>88</volume>
<fpage>165</fpage>
<lpage>241</lpage>
<?supplied-pmid 25911368?><pub-id pub-id-type="pmid">25911368</pub-id></element-citation></ref><ref id="B13-pathogens-05-00059"><label>13.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Requena-M&#x000e9;ndez</surname><given-names>A.</given-names></name><name><surname>Chiodini</surname><given-names>P.</given-names></name><name><surname>Bisoffi</surname><given-names>Z.</given-names></name><name><surname>Buonfrate</surname><given-names>D.</given-names></name><name><surname>Gotuzzo</surname><given-names>E.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>J.</given-names></name></person-group>
<article-title>The laboratory diagnosis and follow up of strongyloidiasis: A systematic review</article-title>
<source>PLoS Negl. Trop. Dis.</source>
<year>2013</year>
<volume>7</volume>
<elocation-id>e2002</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0002002</pub-id>
<?supplied-pmid 23350004?><pub-id pub-id-type="pmid">23350004</pub-id></element-citation></ref><ref id="B14-pathogens-05-00059"><label>14.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Croker</surname><given-names>C.</given-names></name><name><surname>Reporter</surname><given-names>R.</given-names></name><name><surname>Redelings</surname><given-names>M.</given-names></name><name><surname>Mascola</surname><given-names>L.</given-names></name></person-group>
<article-title>Strongyloidiasis-related deaths in the united states, 1991&#x02013;2006</article-title>
<source>Am. J. Trop. Med. Hyg.</source>
<year>2010</year>
<volume>83</volume>
<fpage>422</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="doi">10.4269/ajtmh.2010.09-0750</pub-id>
<?supplied-pmid 20682893?><pub-id pub-id-type="pmid">20682893</pub-id></element-citation></ref><ref id="B15-pathogens-05-00059"><label>15.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muennig</surname><given-names>P.</given-names></name><name><surname>Pallin</surname><given-names>D.</given-names></name><name><surname>Sell</surname><given-names>R.L.</given-names></name><name><surname>Chan</surname><given-names>M.-S.</given-names></name></person-group>
<article-title>The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants</article-title>
<source>N. Engl. J. Med.</source>
<year>1999</year>
<volume>340</volume>
<fpage>773</fpage>
<lpage>779</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199903113401006</pub-id>
<?supplied-pmid 10072413?><pub-id pub-id-type="pmid">10072413</pub-id></element-citation></ref><ref id="B16-pathogens-05-00059"><label>16.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chu</surname><given-names>E.</given-names></name><name><surname>Whitlock</surname><given-names>W.L.</given-names></name><name><surname>Dietrich</surname><given-names>R.A.</given-names></name></person-group>
<article-title>Pulmonary hyperinfection syndrome with strongyloides stercoralis</article-title>
<source>Chest</source>
<year>1990</year>
<volume>97</volume>
<fpage>1475</fpage>
<lpage>1477</lpage>
<pub-id pub-id-type="doi">10.1378/chest.97.6.1475</pub-id>
<pub-id pub-id-type="pmid">2347234</pub-id></element-citation></ref><ref id="B17-pathogens-05-00059"><label>17.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Woodring</surname><given-names>J.H.</given-names></name><name><surname>Halfhill</surname><given-names>H.</given-names><suffix>2nd</suffix></name><name><surname>Reed</surname><given-names>J.C.</given-names></name></person-group>
<article-title>Pulmonary strongyloidiasis: Clinical and imaging features</article-title>
<source>Am. J. Roentgenol.</source>
<year>1994</year>
<volume>162</volume>
<fpage>537</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.2214/ajr.162.3.8109492</pub-id>
<?supplied-pmid 8109492?><pub-id pub-id-type="pmid">8109492</pub-id></element-citation></ref><ref id="B18-pathogens-05-00059"><label>18.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oka</surname><given-names>Y.</given-names></name><name><surname>Shuker</surname><given-names>S.</given-names></name><name><surname>Tkachi</surname><given-names>N.</given-names></name></person-group>
<article-title>Nematicidal efficacy of mcw-2, a new nematicide of the fluoroalkenyl group, against the root-knot nematode meloidogyne javanica</article-title>
<source>Pest Manag. Sci.</source>
<year>2009</year>
<volume>65</volume>
<fpage>1082</fpage>
<lpage>1089</lpage>
<pub-id pub-id-type="doi">10.1002/ps.1796</pub-id>
<?supplied-pmid 19488996?><pub-id pub-id-type="pmid">19488996</pub-id></element-citation></ref><ref id="B19-pathogens-05-00059"><label>19.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Namisato</surname><given-names>S.</given-names></name><name><surname>Motomura</surname><given-names>K.</given-names></name><name><surname>Haranaga</surname><given-names>S.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name><name><surname>Toyama</surname><given-names>M.</given-names></name><name><surname>Shinzato</surname><given-names>T.</given-names></name><name><surname>Higa</surname><given-names>F.</given-names></name><name><surname>Saito</surname><given-names>A.</given-names></name></person-group>
<article-title>Pulmonary strongyloidiasis in a patient receiving prednisolone therapy</article-title>
<source>Intern. Med.</source>
<year>2004</year>
<volume>43</volume>
<fpage>731</fpage>
<lpage>736</lpage>
<pub-id pub-id-type="doi">10.2169/internalmedicine.43.731</pub-id>
<?supplied-pmid 15468976?><pub-id pub-id-type="pmid">15468976</pub-id></element-citation></ref><ref id="B20-pathogens-05-00059"><label>20.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garrard</surname><given-names>T.A.</given-names></name><name><surname>Ross</surname><given-names>K.E.</given-names></name><name><surname>Taylor</surname><given-names>M.J.</given-names></name></person-group>
<article-title>Biocontrol for environmental control of the human parasite, strongyloides stercoralis: A necessary next step</article-title>
<source>Biol. Control</source>
<year>2016</year>
<volume>100</volume>
<fpage>25</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1016/j.biocontrol.2016.05.002</pub-id>
</element-citation></ref><ref id="B21-pathogens-05-00059"><label>21.</label><element-citation publication-type="book">
<person-group person-group-type="author"><collab>WHO</collab></person-group>
<source>Deworming for Health and Development: Report of the Third Global Meeting of the Partners for Parasite Control</source>
<publisher-name>World Health Organisation</publisher-name>
<publisher-loc>Geneva, Switzerland</publisher-loc>
<year>2005</year>
</element-citation></ref><ref id="B22-pathogens-05-00059"><label>22.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taylor</surname><given-names>M.J.</given-names></name><name><surname>Garrard</surname><given-names>T.A.</given-names></name><name><surname>O'Donahoo</surname><given-names>F.J.</given-names></name><name><surname>Ross</surname><given-names>K.E.</given-names></name></person-group>
<article-title>Human strongyloidiasis: Identifying knowledge gaps, with emphasis on environmental control</article-title>
<source>Res. Rep. Trop. Med.</source>
<year>2014</year>
<volume>3</volume>
<fpage>55</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.2147/RRTM.S63138</pub-id>
</element-citation></ref><ref id="B23-pathogens-05-00059"><label>23.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knopp</surname><given-names>S.</given-names></name><name><surname>Mohammed</surname><given-names>K.A.</given-names></name><name><surname>Khamis</surname><given-names>I.S.</given-names></name><name><surname>Mgeni</surname><given-names>A.F.</given-names></name><name><surname>Stothard</surname><given-names>J.R.</given-names></name><name><surname>Rollinson</surname><given-names>D.</given-names></name><name><surname>Marti</surname><given-names>H.</given-names></name><name><surname>Utzinger</surname><given-names>J.</given-names></name></person-group>
<article-title>Spatial distribution of soil-transmitted helminths, including strongyloides stercoralis, among children in zanzibar</article-title>
<source>Geosp. Health</source>
<year>2008</year>
<volume>3</volume>
<fpage>47</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.4081/gh.2008.231</pub-id>
<?supplied-pmid 19021108?><pub-id pub-id-type="pmid">19021108</pub-id></element-citation></ref><ref id="B24-pathogens-05-00059"><label>24.</label><element-citation publication-type="book">
<person-group person-group-type="author"><collab>World Health Organisation</collab></person-group>
<source>Preventive Chemotherapy in Human Helminthiasis</source>
<publisher-name>World Health Organisation</publisher-name>
<publisher-loc>Geneva, Switzerland</publisher-loc>
<year>2006</year>
</element-citation></ref><ref id="B25-pathogens-05-00059"><label>25.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toma</surname><given-names>H.</given-names></name><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Shiroma</surname><given-names>Y.</given-names></name><name><surname>Kobayashi</surname><given-names>J.</given-names></name><name><surname>Shimabukuro</surname><given-names>I.</given-names></name><name><surname>Takara</surname><given-names>M.</given-names></name></person-group>
<article-title>Comparative studies on the efficacy of three anthelmintics on treatment of human strongyloidiasis in okinawa, Japan</article-title>
<source>Southeast Asian J. Trop. Med. Public Health</source>
<year>2000</year>
<volume>31</volume>
<fpage>147</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="pmid">11023084</pub-id></element-citation></ref><ref id="B26-pathogens-05-00059"><label>26.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nontasut</surname><given-names>P.</given-names></name><name><surname>Muennoo</surname><given-names>C.</given-names></name><name><surname>Sa-nguankiat</surname><given-names>S.</given-names></name><name><surname>Fongsri</surname><given-names>S.</given-names></name><name><surname>Vichit</surname><given-names>A.</given-names></name></person-group>
<article-title>Prevalence of strongyloides in northern thailand and treatment with ivermectin vs albendazole</article-title>
<source>Southeast Asian J. Trop. Med. Public Health</source>
<year>2005</year>
<volume>36</volume>
<fpage>442</fpage>
<pub-id pub-id-type="pmid">15916052</pub-id></element-citation></ref><ref id="B27-pathogens-05-00059"><label>27.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Igual-Adell</surname><given-names>R.</given-names></name><name><surname>Oltra-Alcaraz</surname><given-names>C.</given-names></name><name><surname>Soler-Company</surname><given-names>E.</given-names></name><name><surname>S&#x000e1;nchez-S&#x000e1;nchez</surname><given-names>P.</given-names></name><name><surname>Matogo-Oyana</surname><given-names>J.</given-names></name><name><surname>Rodr&#x000ed;guez-Calabuig</surname><given-names>D.</given-names></name></person-group>
<article-title>Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis</article-title>
<source>Expert Opin. Pharmacother.</source>
<year>2004</year>
<volume>5</volume>
<fpage>2615</fpage>
<lpage>2619</lpage>
<pub-id pub-id-type="doi">10.1517/14656566.5.12.2615</pub-id>
<?supplied-pmid 15571478?><pub-id pub-id-type="pmid">15571478</pub-id></element-citation></ref><ref id="B28-pathogens-05-00059"><label>28.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>R.M.</given-names></name><name><surname>Klei</surname><given-names>T.R.</given-names></name><name><surname>Lyons</surname><given-names>E.T.</given-names></name><name><surname>Lester</surname><given-names>G.</given-names></name><name><surname>Courtney</surname><given-names>C.H.</given-names></name><name><surname>French</surname><given-names>D.D.</given-names></name><name><surname>Tolliver</surname><given-names>S.C.</given-names></name><name><surname>Vidyashankar</surname><given-names>A.N.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name></person-group>
<article-title>Prevalence of anthelmintic resistant cyathostomes on horse farms</article-title>
<source>J. Am. Vet. Med. Assoc.</source>
<year>2004</year>
<volume>225</volume>
<fpage>903</fpage>
<lpage>910</lpage>
<pub-id pub-id-type="doi">10.2460/javma.2004.225.903</pub-id>
<?supplied-pmid 15485051?><pub-id pub-id-type="pmid">15485051</pub-id></element-citation></ref><ref id="B29-pathogens-05-00059"><label>29.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maroto</surname><given-names>R.</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>A.</given-names></name><name><surname>Romero</surname><given-names>J.</given-names></name><name><surname>Alvarez</surname><given-names>V.</given-names></name><name><surname>de Oliveira</surname><given-names>J.</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>J.</given-names></name></person-group>
<article-title>First report of anthelmintic resistance in gastrointestinal nematodes of sheep from costa rica</article-title>
<source>Vet. Med. Int.</source>
<year>2011</year>
<volume>2011</volume>
<pub-id pub-id-type="doi">10.4061/2011/145312</pub-id>
<?supplied-pmid 21772962?><pub-id pub-id-type="pmid">21772962</pub-id></element-citation></ref><ref id="B30-pathogens-05-00059"><label>30.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>E.</given-names></name><name><surname>Al-Farwachi</surname><given-names>M.</given-names></name></person-group>
<article-title>Evaluation the effect of albendazole against nematodes in sheep in mosul, iraq</article-title>
<source>Iraqi J. Vet. Sci.</source>
<year>2008</year>
<volume>22</volume>
<fpage>5</fpage>
<lpage>7</lpage>
</element-citation></ref><ref id="B31-pathogens-05-00059"><label>31.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Molento</surname><given-names>M.B.</given-names></name></person-group>
<article-title>Parasite control in the age of drug resistance and changing agricultural practices</article-title>
<source>Vet. Parasitol.</source>
<year>2009</year>
<volume>163</volume>
<fpage>229</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1016/j.vetpar.2009.06.007</pub-id>
<?supplied-pmid 19560869?><pub-id pub-id-type="pmid">19560869</pub-id></element-citation></ref><ref id="B32-pathogens-05-00059"><label>32.</label><element-citation publication-type="webpage">
<person-group person-group-type="author"><name><surname>Holden-Dye</surname><given-names>L.</given-names></name><name><surname>Walker</surname><given-names>R.J.</given-names></name></person-group>
<article-title>Anthelmintic Drugs and Nematicides: Studies in Caenorhabditis Elegans</article-title>
<year>2005</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK116072">https://www.ncbi.nlm.nih.gov/books/NBK116072</ext-link></comment>
<date-in-citation>(accessed on 30 September 2016)</date-in-citation>
</element-citation></ref><ref id="B33-pathogens-05-00059"><label>33.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Venkatesan</surname><given-names>P.</given-names></name></person-group>
<article-title>Albendazole</article-title>
<source>J. Antimicrob. Chemother.</source>
<year>1998</year>
<volume>41</volume>
<fpage>145</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1093/jac/41.2.145</pub-id>
<pub-id pub-id-type="pmid">9533454</pub-id></element-citation></ref><ref id="B34-pathogens-05-00059"><label>34.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Horton</surname><given-names>J.</given-names></name></person-group>
<article-title>Albendazole: A review of anthelmintic efficacy and safety in humans</article-title>
<source>Parasitology</source>
<year>2000</year>
<volume>121</volume>
<fpage>S113</fpage>
<lpage>S132</lpage>
<pub-id pub-id-type="doi">10.1017/S0031182000007290</pub-id>
<?supplied-pmid 11386684?><pub-id pub-id-type="pmid">11386684</pub-id></element-citation></ref><ref id="B35-pathogens-05-00059"><label>35.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geary</surname><given-names>T.G.</given-names></name><name><surname>Woo</surname><given-names>K.</given-names></name><name><surname>McCarthy</surname><given-names>J.S.</given-names></name><name><surname>Mackenzie</surname><given-names>C.D.</given-names></name><name><surname>Horton</surname><given-names>J.</given-names></name><name><surname>Prichard</surname><given-names>R.K.</given-names></name><name><surname>de Silva</surname><given-names>N.R.</given-names></name><name><surname>Olliaro</surname><given-names>P.L.</given-names></name><name><surname>Lazdins-Helds</surname><given-names>J.K.</given-names></name><name><surname>Engels</surname><given-names>D.A.</given-names></name></person-group>
<article-title>Unresolved issues in anthelmintic pharmacology for helminthiases of humans</article-title>
<source>Int. J. Parasitol.</source>
<year>2010</year>
<volume>40</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijpara.2009.11.001</pub-id>
<?supplied-pmid 19932111?><pub-id pub-id-type="pmid">19932111</pub-id></element-citation></ref><ref id="B36-pathogens-05-00059"><label>36.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cully</surname><given-names>D.F.</given-names></name><name><surname>Vassilatis</surname><given-names>D.K.</given-names></name><name><surname>Liu</surname><given-names>K.K.</given-names></name><name><surname>Paress</surname><given-names>P.S.</given-names></name><name><surname>van der Ploeg</surname><given-names>L.</given-names></name><name><surname>Schaeffer</surname><given-names>J.M.</given-names></name><name><surname>Arena</surname><given-names>J.P.</given-names></name></person-group>
<article-title>Cloning of an avermectin-sensitive glutamate-gated chloride channel from caenorhabditis elegans</article-title>
<source>Nature</source>
<year>1994</year>
<volume>371</volume>
<fpage>707</fpage>
<lpage>711</lpage>
<pub-id pub-id-type="doi">10.1038/371707a0</pub-id>
<?supplied-pmid 7935817?><pub-id pub-id-type="pmid">7935817</pub-id></element-citation></ref><ref id="B37-pathogens-05-00059"><label>37.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ottesen</surname><given-names>E.A.</given-names></name><name><surname>Campbell</surname><given-names>W.</given-names></name></person-group>
<article-title>Ivermectin in human medicine</article-title>
<source>J. Antimicrob. Chemother.</source>
<year>1994</year>
<volume>34</volume>
<fpage>195</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1093/jac/34.2.195</pub-id>
<pub-id pub-id-type="pmid">7814280</pub-id></element-citation></ref><ref id="B38-pathogens-05-00059"><label>38.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hotez</surname><given-names>P.</given-names></name></person-group>
<article-title>Mass drug administration and integrated control for the world&#x02019;s high-prevalence neglected tropical diseases</article-title>
<source>Clin. Pharmacol. Ther.</source>
<year>2009</year>
<volume>85</volume>
<fpage>659</fpage>
<lpage>664</lpage>
<pub-id pub-id-type="doi">10.1038/clpt.2009.16</pub-id>
<?supplied-pmid 19322166?><pub-id pub-id-type="pmid">19322166</pub-id></element-citation></ref><ref id="B39-pathogens-05-00059"><label>39.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hauber</surname><given-names>H.</given-names></name><name><surname>Galle</surname><given-names>J.</given-names></name><name><surname>Chiodini</surname><given-names>P.</given-names></name><name><surname>Rupp</surname><given-names>J.</given-names></name><name><surname>Birke</surname><given-names>R.</given-names></name><name><surname>Vollmer</surname><given-names>E.</given-names></name><name><surname>Zabel</surname><given-names>P.</given-names></name><name><surname>Lange</surname><given-names>C.</given-names></name></person-group>
<article-title>Fatal outcome of a hyperinfection syndrome despite successful eradication of strongyloides with subcutaneous ivermectin</article-title>
<source>Infection</source>
<year>2005</year>
<volume>33</volume>
<fpage>383</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1007/s15010-005-5060-x</pub-id>
<?supplied-pmid 16258873?><pub-id pub-id-type="pmid">16258873</pub-id></element-citation></ref><ref id="B40-pathogens-05-00059"><label>40.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turner</surname><given-names>S.A.</given-names></name><name><surname>MacLean</surname><given-names>J.D.</given-names></name><name><surname>Fleckenstein</surname><given-names>L.</given-names></name><name><surname>Greenaway</surname><given-names>C.</given-names></name></person-group>
<article-title>Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis</article-title>
<source>Am. J. Trop. Med. Hyg.</source>
<year>2005</year>
<volume>73</volume>
<fpage>911</fpage>
<lpage>914</lpage>
<pub-id pub-id-type="pmid">16282302</pub-id></element-citation></ref><ref id="B41-pathogens-05-00059"><label>41.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coles</surname><given-names>G.</given-names></name><name><surname>Jackson</surname><given-names>F.</given-names></name><name><surname>Pomroy</surname><given-names>W.</given-names></name><name><surname>Prichard</surname><given-names>R.</given-names></name><name><surname>von Samson-Himmelstjerna</surname><given-names>G.</given-names></name><name><surname>Silvestre</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>M.</given-names></name><name><surname>Vercruysse</surname><given-names>J.</given-names></name></person-group>
<article-title>The detection of anthelmintic resistance in nematodes of veterinary importance</article-title>
<source>Vet. Parasitol.</source>
<year>2006</year>
<volume>136</volume>
<fpage>167</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.1016/j.vetpar.2005.11.019</pub-id>
<?supplied-pmid 16427201?><pub-id pub-id-type="pmid">16427201</pub-id></element-citation></ref><ref id="B42-pathogens-05-00059"><label>42.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>R.M.</given-names></name></person-group>
<article-title>Drug resistance in nematodes of veterinary importance: A status report</article-title>
<source>Trends Parasitol.</source>
<year>2004</year>
<volume>20</volume>
<fpage>477</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="doi">10.1016/j.pt.2004.08.001</pub-id>
<?supplied-pmid 15363441?><pub-id pub-id-type="pmid">15363441</pub-id></element-citation></ref><ref id="B43-pathogens-05-00059"><label>43.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paula</surname><given-names>F.</given-names></name><name><surname>Costa-Cruz</surname><given-names>J.</given-names></name></person-group>
<article-title>Epidemiological aspects of strongyloidiasis in brazil</article-title>
<source>Parasitology</source>
<year>2011</year>
<volume>138</volume>
<fpage>1331</fpage>
<pub-id pub-id-type="doi">10.1017/S003118201100120X</pub-id>
<?supplied-pmid 21810305?><pub-id pub-id-type="pmid">21810305</pub-id></element-citation></ref><ref id="B44-pathogens-05-00059"><label>44.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vadlamudi</surname><given-names>R.S.</given-names></name><name><surname>Chi</surname><given-names>D.S.</given-names></name><name><surname>Krishnaswamy</surname><given-names>G.</given-names></name></person-group>
<article-title>Intestinal strongyloidiasis and hyperinfection syndrome</article-title>
<source>Clin. Mol. Allergy</source>
<year>2006</year>
<volume>4</volume>
<fpage>1</fpage>
<pub-id pub-id-type="doi">10.1186/1476-7961-4-8</pub-id>
<?supplied-pmid 16734908?><pub-id pub-id-type="pmid">16478539</pub-id></element-citation></ref><ref id="B45-pathogens-05-00059"><label>45.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scowden</surname><given-names>E.B.</given-names></name><name><surname>Schaffner</surname><given-names>W.</given-names></name><name><surname>Stone</surname><given-names>W.J.</given-names></name></person-group>
<article-title>Overwhelming strongyloidiasis: An unappreciated opportunistic infection</article-title>
<source>Medicine</source>
<year>1978</year>
<volume>57</volume>
<fpage>527</fpage>
<lpage>544</lpage>
<pub-id pub-id-type="doi">10.1097/00005792-197811000-00004</pub-id>
<?supplied-pmid 362122?><pub-id pub-id-type="pmid">362122</pub-id></element-citation></ref><ref id="B46-pathogens-05-00059"><label>46.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>E.</given-names></name><name><surname>da Fonseca Porto</surname><given-names>A.</given-names></name></person-group>
<article-title>Epidemiological and clinical interaction between htlv-1 and strongyloides stercoralis</article-title>
<source>Parasite Immunol.</source>
<year>2004</year>
<volume>26</volume>
<fpage>487</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="doi">10.1111/j.0141-9838.2004.00726.x</pub-id>
<?supplied-pmid 15771684?><pub-id pub-id-type="pmid">15771684</pub-id></element-citation></ref><ref id="B47-pathogens-05-00059"><label>47.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sultana</surname><given-names>Y.</given-names></name><name><surname>Gilbert</surname><given-names>G.L.</given-names></name><name><surname>Ahmed</surname><given-names>B.-N.</given-names></name><name><surname>Lee</surname><given-names>R.</given-names></name></person-group>
<article-title>Strongyloidiasis in a high risk community of dhaka, bangladesh</article-title>
<source>Trans. R. Soc. Trop. Med. Hyg.</source>
<year>2012</year>
<volume>106</volume>
<fpage>756</fpage>
<lpage>762</lpage>
<pub-id pub-id-type="doi">10.1016/j.trstmh.2012.08.011</pub-id>
<?supplied-pmid 23084030?><pub-id pub-id-type="pmid">23084030</pub-id></element-citation></ref><ref id="B48-pathogens-05-00059"><label>48.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Buonfrate</surname><given-names>D.</given-names></name><name><surname>Formenti</surname><given-names>F.</given-names></name><name><surname>Perandin</surname><given-names>F.</given-names></name><name><surname>Bisoffi</surname><given-names>Z.</given-names></name></person-group>
<article-title>Novel approaches to the diagnosis of strongyloides stercoralis infection</article-title>
<source>Clin. Microbiol. Infect.</source>
<year>2015</year>
<volume>21</volume>
<fpage>543</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmi.2015.04.001</pub-id>
<?supplied-pmid 25887711?><pub-id pub-id-type="pmid">25887711</pub-id></element-citation></ref><ref id="B49-pathogens-05-00059"><label>49.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Buonfrate</surname><given-names>D.</given-names></name><name><surname>Sequi</surname><given-names>M.</given-names></name><name><surname>Mejia</surname><given-names>R.</given-names></name><name><surname>Cimino</surname><given-names>R.O.</given-names></name><name><surname>Krolewiecki</surname><given-names>A.J.</given-names></name><name><surname>Albonico</surname><given-names>M.</given-names></name><name><surname>Degani</surname><given-names>M.</given-names></name><name><surname>Tais</surname><given-names>S.</given-names></name><name><surname>Angheben</surname><given-names>A.</given-names></name><name><surname>Requena-Mendez</surname><given-names>A.</given-names></name></person-group>
<article-title>Accuracy of five serologic tests for the follow up of strongyloides stercoralis infection</article-title>
<source>PLoS Negl. Trop. Dis.</source>
<year>2015</year>
<volume>9</volume>
<elocation-id>e0003491</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0003491</pub-id>
<?supplied-pmid 25668740?><pub-id pub-id-type="pmid">25668740</pub-id></element-citation></ref><ref id="B50-pathogens-05-00059"><label>50.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shikiya</surname><given-names>K.</given-names></name><name><surname>Zaha</surname><given-names>O.</given-names></name><name><surname>Niimura</surname><given-names>S.</given-names></name><name><surname>Uehara</surname><given-names>T.</given-names></name><name><surname>Ohshiro</surname><given-names>J.</given-names></name><name><surname>Kinjo</surname><given-names>F.</given-names></name><name><surname>Saito</surname><given-names>A.</given-names></name><name><surname>Asato</surname><given-names>R.</given-names></name></person-group>
<article-title>[clinical study on ivermectin against 125 strongyloidiasis patients]</article-title>
<source>Kansenshogaku Zasshi</source>
<year>1994</year>
<volume>68</volume>
<fpage>13</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.11150/kansenshogakuzasshi1970.68.13</pub-id>
<pub-id pub-id-type="pmid">8138669</pub-id></element-citation></ref><ref id="B51-pathogens-05-00059"><label>51.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zaha</surname><given-names>O.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name><name><surname>Kinjo</surname><given-names>F.</given-names></name><name><surname>Saito</surname><given-names>A.</given-names></name><name><surname>Fukuhara</surname><given-names>H.</given-names></name></person-group>
<article-title>Efficacy of ivermectin for chronic strongyloidiasis: Two single doses given 2 weeks apart</article-title>
<source>J. Infect. Chemother.</source>
<year>2002</year>
<volume>8</volume>
<fpage>94</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1007/s101560200013</pub-id>
<?supplied-pmid 11957127?><pub-id pub-id-type="pmid">11957127</pub-id></element-citation></ref><ref id="B52-pathogens-05-00059"><label>52.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lichtenberger</surname><given-names>P.</given-names></name><name><surname>Rosa-Cunha</surname><given-names>I.</given-names></name><name><surname>Morris</surname><given-names>M.</given-names></name><name><surname>Nishida</surname><given-names>S.</given-names></name><name><surname>Akpinar</surname><given-names>E.</given-names></name><name><surname>Gaitan</surname><given-names>J.</given-names></name><name><surname>Tzakis</surname><given-names>A.</given-names></name><name><surname>Doblecki-Lewis</surname><given-names>S.</given-names></name></person-group>
<article-title>Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin</article-title>
<source>Transpl. Infect. Dis.</source>
<year>2009</year>
<volume>11</volume>
<fpage>137</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-3062.2008.00358.x</pub-id>
<?supplied-pmid 19144097?><pub-id pub-id-type="pmid">19144097</pub-id></element-citation></ref><ref id="B53-pathogens-05-00059"><label>53.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marti</surname><given-names>H.</given-names></name><name><surname>Haji</surname><given-names>H.J.</given-names></name><name><surname>Savioli</surname><given-names>L.</given-names></name><name><surname>Chwaya</surname><given-names>H.M.</given-names></name><name><surname>Mgeni</surname><given-names>A.F.</given-names></name><name><surname>Ameir</surname><given-names>J.S.</given-names></name><name><surname>Hatz</surname><given-names>C.</given-names></name></person-group>
<article-title>A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of strongyloides stercoralis and other soil-transmitted helminth infections in children</article-title>
<source>Am. J. Trop. Med. Hyg.</source>
<year>1996</year>
<volume>55</volume>
<fpage>477</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="pmid">8940976</pub-id></element-citation></ref><ref id="B54-pathogens-05-00059"><label>54.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Silva</surname><given-names>N.</given-names></name><name><surname>Guyatt</surname><given-names>H.</given-names></name><name><surname>Bundy</surname><given-names>D.</given-names></name></person-group>
<article-title>Anthelmintics</article-title>
<source>Drugs</source>
<year>1997</year>
<volume>53</volume>
<fpage>769</fpage>
<lpage>788</lpage>
<pub-id pub-id-type="doi">10.2165/00003495-199753050-00004</pub-id>
<?supplied-pmid 9129865?><pub-id pub-id-type="pmid">9129865</pub-id></element-citation></ref><ref id="B55-pathogens-05-00059"><label>55.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Waghorn</surname><given-names>T.</given-names></name><name><surname>Leathwick</surname><given-names>D.</given-names></name><name><surname>Rhodes</surname><given-names>A.</given-names></name><name><surname>Lawrence</surname><given-names>K.</given-names></name><name><surname>Jackson</surname><given-names>R.</given-names></name><name><surname>Pomroy</surname><given-names>W.</given-names></name><name><surname>West</surname><given-names>D.</given-names></name><name><surname>Moffat</surname><given-names>J.</given-names></name></person-group>
<article-title>Prevalence of anthelmintic resistance on sheep farms in new zealand</article-title>
<source>N. Z. Vet. J.</source>
<year>2006</year>
<volume>54</volume>
<fpage>271</fpage>
<lpage>277</lpage>
<pub-id pub-id-type="doi">10.1080/00480169.2006.36710</pub-id>
<?supplied-pmid 17151724?><pub-id pub-id-type="pmid">17151724</pub-id></element-citation></ref><ref id="B56-pathogens-05-00059"><label>56.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sutherland</surname><given-names>I.A.</given-names></name><name><surname>Leathwick</surname><given-names>D.M.</given-names></name></person-group>
<article-title>Anthelmintic resistance in nematode parasites of cattle: A global issue?</article-title>
<source>Trends Parasitol.</source>
<year>2011</year>
<volume>27</volume>
<fpage>176</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1016/j.pt.2010.11.008</pub-id>
<?supplied-pmid 21168366?><pub-id pub-id-type="pmid">21168366</pub-id></element-citation></ref><ref id="B57-pathogens-05-00059"><label>57.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>R.M.</given-names></name><name><surname>Vidyashankar</surname><given-names>A.N.</given-names></name></person-group>
<article-title>An inconvenient truth: Global worming and anthelmintic resistance</article-title>
<source>Vet. Parasitol.</source>
<year>2012</year>
<volume>186</volume>
<fpage>70</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1016/j.vetpar.2011.11.048</pub-id>
<?supplied-pmid 22154968?><pub-id pub-id-type="pmid">22154968</pub-id></element-citation></ref><ref id="B58-pathogens-05-00059"><label>58.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prichard</surname><given-names>R.</given-names></name></person-group>
<article-title>Anthelmintic resistance</article-title>
<source>Vet. Parasitol.</source>
<year>1994</year>
<volume>54</volume>
<fpage>259</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1016/0304-4017(94)90094-9</pub-id>
<pub-id pub-id-type="pmid">7846855</pub-id></element-citation></ref><ref id="B59-pathogens-05-00059"><label>59.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Besier</surname><given-names>R.</given-names></name><name><surname>Love</surname><given-names>S.</given-names></name></person-group>
<article-title>Anthelmintic resistance in sheep nematodes in australia: The need for new approaches</article-title>
<source>Anim. Prod. Sci.</source>
<year>2004</year>
<volume>43</volume>
<fpage>1383</fpage>
<lpage>1391</lpage>
<pub-id pub-id-type="doi">10.1071/EA02229</pub-id>
</element-citation></ref><ref id="B60-pathogens-05-00059"><label>60.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Satoh</surname><given-names>M.</given-names></name><name><surname>Toma</surname><given-names>H.</given-names></name><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Kikuchi</surname><given-names>M.</given-names></name><name><surname>Takara</surname><given-names>M.</given-names></name><name><surname>Shiroma</surname><given-names>Y.</given-names></name><name><surname>Kiyuna</surname><given-names>S.</given-names></name><name><surname>Hirayama</surname><given-names>K.</given-names></name></person-group>
<article-title>Production of a high level of specific igg4 antibody associated with resistance to albendazole treatment in hla-drb1* 0901-positive patients with strongyloidiasis</article-title>
<source>Am. J. Trop. Med. Hyg.</source>
<year>1999</year>
<volume>61</volume>
<fpage>668</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="pmid">10548308</pub-id></element-citation></ref><ref id="B61-pathogens-05-00059"><label>61.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Albonico</surname><given-names>M.</given-names></name><name><surname>Engels</surname><given-names>D.</given-names></name><name><surname>Savioli</surname><given-names>L.</given-names></name></person-group>
<article-title>Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: A pressing public health agenda for helminth control</article-title>
<source>Int. J. Parasitol.</source>
<year>2004</year>
<volume>34</volume>
<fpage>1205</fpage>
<lpage>1210</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijpara.2004.08.001</pub-id>
<?supplied-pmid 15491582?><pub-id pub-id-type="pmid">15491582</pub-id></element-citation></ref><ref id="B62-pathogens-05-00059"><label>62.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Clercq</surname><given-names>D.</given-names></name><name><surname>Sacko</surname><given-names>M.</given-names></name><name><surname>Behnke</surname><given-names>J.</given-names></name><name><surname>Gilbert</surname><given-names>F.</given-names></name><name><surname>Dorny</surname><given-names>P.</given-names></name><name><surname>Vercruysse</surname><given-names>J.</given-names></name></person-group>
<article-title>Failure of mebendazole in treatment of human hookworm infections in the southern region of mali</article-title>
<source>Am. J. Trop. Med. Hyg.</source>
<year>1997</year>
<volume>57</volume>
<fpage>25</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">9242313</pub-id></element-citation></ref><ref id="B63-pathogens-05-00059"><label>63.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Molento</surname><given-names>M.</given-names></name><name><surname>Blackhall</surname><given-names>W.</given-names></name><name><surname>Ribeiro</surname><given-names>P.</given-names></name><name><surname>Beech</surname><given-names>R.</given-names></name><name><surname>Prichard</surname><given-names>R.</given-names></name></person-group>
<article-title>Ivermectin resistance in nematodes may be caused by alteration of p-glycoprotein homolog</article-title>
<source>Mol. Biochem. Parasitol.</source>
<year>1998</year>
<volume>91</volume>
<fpage>327</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="doi">10.1016/S0166-6851(97)00215-6</pub-id>
<pub-id pub-id-type="pmid">9566525</pub-id></element-citation></ref><ref id="B64-pathogens-05-00059"><label>64.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>James</surname><given-names>C.E.</given-names></name><name><surname>Davey</surname><given-names>M.W.</given-names></name></person-group>
<article-title>Increased expression of abc transport proteins is associated with ivermectin resistance in the model nematode caenorhabditis elegans</article-title>
<source>Int. J. Parasitol.</source>
<year>2009</year>
<volume>39</volume>
<fpage>213</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijpara.2008.06.009</pub-id>
<?supplied-pmid 18708066?><pub-id pub-id-type="pmid">18708066</pub-id></element-citation></ref><ref id="B65-pathogens-05-00059"><label>65.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gilleard</surname><given-names>J.</given-names></name><name><surname>Beech</surname><given-names>R.</given-names></name></person-group>
<article-title>Anthelmintic resistance: Markers for resistance, or susceptibility</article-title>
<source>Parasitology</source>
<year>2011</year>
<volume>138</volume>
<fpage>160</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="pmid">20825689</pub-id></element-citation></ref><ref id="B66-pathogens-05-00059"><label>66.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prichard</surname><given-names>R.K.</given-names></name></person-group>
<article-title>Markers for benzimidazole resistance in human parasitic nematodes?</article-title>
<source>Parasitology</source>
<year>2007</year>
<volume>134</volume>
<fpage>1087</fpage>
<lpage>1092</lpage>
<pub-id pub-id-type="doi">10.1017/S003118200700008X</pub-id>
<?supplied-pmid 17608968?><pub-id pub-id-type="pmid">17608968</pub-id></element-citation></ref><ref id="B67-pathogens-05-00059"><label>67.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geerts</surname><given-names>S.</given-names></name><name><surname>Gryseels</surname><given-names>B.</given-names></name></person-group>
<article-title>Drug resistance in human helminths: Current situation and lessons from livestock</article-title>
<source>Clin. Microbiol. Rev.</source>
<year>2000</year>
<volume>13</volume>
<fpage>207</fpage>
<lpage>222</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.13.2.207-222.2000</pub-id>
<?supplied-pmid 10755998?><pub-id pub-id-type="pmid">10755998</pub-id></element-citation></ref><ref id="B68-pathogens-05-00059"><label>68.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smits</surname><given-names>H.L.</given-names></name></person-group>
<article-title>Prospects for the control of neglected tropical diseases by mass drug administration</article-title>
<source>Expert Rev. Anti-Infect. Ther.</source>
<year>2009</year>
<volume>7</volume>
<fpage>37</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1586/14787210.7.1.37</pub-id>
<?supplied-pmid 19622056?><pub-id pub-id-type="pmid">19622056</pub-id></element-citation></ref><ref id="B69-pathogens-05-00059"><label>69.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Askary</surname><given-names>T.H.</given-names></name></person-group>
<article-title>19 limitations, research needs and future prospects in the biological control of phytonematodes</article-title>
<source>Biocontrol Agents Phytonematodes</source>
<year>2015</year>
<fpage>446</fpage>
</element-citation></ref><ref id="B70-pathogens-05-00059"><label>70.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Government</surname><given-names>A.</given-names></name><name><surname>Authority</surname><given-names>V.M.</given-names></name></person-group>
<source>Public Chemical Registration Information System Search</source>
<publisher-name>Australian Pesticides and Veterinary Medicines Authority Australia</publisher-name>
<publisher-loc>Canberra, Australia</publisher-loc>
<year>2016</year>
</element-citation></ref><ref id="B71-pathogens-05-00059"><label>71.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Husain</surname><given-names>K.</given-names></name><name><surname>Ansari</surname><given-names>R.A.</given-names></name><name><surname>Ferder</surname><given-names>L.</given-names></name></person-group>
<article-title>Pharmacological agents in the prophylaxis/treatment of organophosphorous pesticide intoxication</article-title>
<source>Indian J. Exp. Biol.</source>
<year>2010</year>
<volume>48</volume>
<fpage>642</fpage>
<?supplied-pmid 20929049?><pub-id pub-id-type="pmid">20929049</pub-id></element-citation></ref><ref id="B72-pathogens-05-00059"><label>72.</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gupta</surname><given-names>R.C.</given-names></name></person-group>
<source>Toxicology of Organophosphate &#x00026; Carbamate Compounds</source>
<publisher-name>Elservier Academic Press</publisher-name>
<publisher-loc>San Diego, CA, USA</publisher-loc>
<year>2011</year>
</element-citation></ref><ref id="B73-pathogens-05-00059"><label>73.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giannakou</surname><given-names>I.O.</given-names></name><name><surname>Karpouzas</surname><given-names>D.G.</given-names></name></person-group>
<article-title>Evaluation of chemical and integrated strategies as alternatives to methyl bromide for the control of root-knot nematodes in greece</article-title>
<source>Pest Manag. Sci.</source>
<year>2003</year>
<volume>59</volume>
<fpage>883</fpage>
<lpage>892</lpage>
<pub-id pub-id-type="doi">10.1002/ps.692</pub-id>
<?supplied-pmid 12916769?><pub-id pub-id-type="pmid">12916769</pub-id></element-citation></ref><ref id="B74-pathogens-05-00059"><label>74.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kearn</surname><given-names>J.</given-names></name><name><surname>Ludlow</surname><given-names>E.</given-names></name><name><surname>Dillon</surname><given-names>J.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>V.</given-names></name><name><surname>Holden-Dye</surname><given-names>L.</given-names></name></person-group>
<article-title>Fluensulfone is a nematicide with a mode of action distinct from anticholinesterases and macrocyclic lactones</article-title>
<source>Pestic. Biochem. Physiol.</source>
<year>2014</year>
<volume>109</volume>
<fpage>44</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1016/j.pestbp.2014.01.004</pub-id>
<?supplied-pmid 24581383?><pub-id pub-id-type="pmid">24581383</pub-id></element-citation></ref><ref id="B75-pathogens-05-00059"><label>75.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zaki</surname><given-names>M.H.</given-names></name><name><surname>Moran</surname><given-names>D.</given-names></name><name><surname>Harris</surname><given-names>D.</given-names></name></person-group>
<article-title>Pesticides in groundwater: The aldicarb story in suffolk county, NY</article-title>
<source>Am. J. Publ. Health</source>
<year>1982</year>
<volume>72</volume>
<fpage>1391</fpage>
<lpage>1395</lpage>
<pub-id pub-id-type="doi">10.2105/AJPH.72.12.1391</pub-id>
</element-citation></ref><ref id="B76-pathogens-05-00059"><label>76.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bilkert</surname><given-names>J.</given-names></name><name><surname>Rao</surname><given-names>P.</given-names></name></person-group>
<article-title>Sorption and leaching of three nonfumigant nematicides in soils</article-title>
<source>J. Environ. Sci. Health Part B</source>
<year>1985</year>
<volume>20</volume>
<fpage>1</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1080/03601238509372466</pub-id>
</element-citation></ref><ref id="B77-pathogens-05-00059"><label>77.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Otieno</surname><given-names>P.O.</given-names></name><name><surname>Lalah</surname><given-names>J.O.</given-names></name><name><surname>Virani</surname><given-names>M.</given-names></name><name><surname>Jondiko</surname><given-names>I.O.</given-names></name><name><surname>Schramm</surname><given-names>K.-W.</given-names></name></person-group>
<article-title>Carbofuran and its toxic metabolites provide forensic evidence for furadan exposure in vultures (gyps africanus) in kenya</article-title>
<source>Bull. Environ. Contam. Toxicol.</source>
<year>2010</year>
<volume>84</volume>
<fpage>536</fpage>
<lpage>544</lpage>
<pub-id pub-id-type="doi">10.1007/s00128-010-9956-5</pub-id>
<?supplied-pmid 20372877?><pub-id pub-id-type="pmid">20372877</pub-id></element-citation></ref><ref id="B78-pathogens-05-00059"><label>78.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Opperman</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>S.</given-names></name></person-group>
<article-title>Effects of aldicarb and fenamiphos on acetycholinesterase and motility of caenorhabditis elegans</article-title>
<source>J. Nematol.</source>
<year>1991</year>
<volume>23</volume>
<fpage>20</fpage>
<?supplied-pmid 19283090?><pub-id pub-id-type="pmid">19283090</pub-id></element-citation></ref><ref id="B79-pathogens-05-00059"><label>79.</label><element-citation publication-type="book">
<person-group person-group-type="author"><collab>WHO</collab></person-group>
<source>Report of the Joint Meeting of the Fao Panel of Experts on Pesticide Residues in Food and the Environment and the Who Core Assesment Group on Pesticide Residues</source>
<publisher-name>Wolrd Health Organisation, Food and Agriculture Organisation of the United Nations</publisher-name>
<publisher-loc>Geneva, Switzerland</publisher-loc>
<year>2013</year>
</element-citation></ref><ref id="B80-pathogens-05-00059"><label>80.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Silvestre</surname><given-names>A.</given-names></name><name><surname>Cabaret</surname><given-names>J.</given-names></name></person-group>
<article-title>Nematode parasites of animals are more prone to develop xenobiotic resistance than nematode parasites of plants</article-title>
<source>Parasite</source>
<year>2004</year>
<volume>11</volume>
<fpage>119</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="doi">10.1051/parasite/2004112119</pub-id>
<pub-id pub-id-type="pmid">15224572</pub-id></element-citation></ref><ref id="B81-pathogens-05-00059"><label>81.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dobson</surname><given-names>R.J.</given-names></name><name><surname>Lejambre</surname><given-names>L.</given-names></name><name><surname>Gill</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Management of anthelmintic resistance: Inheritance of resistance and selection with persistent drugs</article-title>
<source>Int. J. Parasitol.</source>
<year>1996</year>
<volume>26</volume>
<fpage>993</fpage>
<lpage>1000</lpage>
<pub-id pub-id-type="doi">10.1016/S0020-7519(96)80078-6</pub-id>
<pub-id pub-id-type="pmid">8923146</pub-id></element-citation></ref><ref id="B82-pathogens-05-00059"><label>82.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Below</surname><given-names>S.</given-names></name><name><surname>K&#x000e4;mpfe</surname><given-names>L.</given-names></name><name><surname>Mueller</surname><given-names>A.</given-names></name></person-group>
<article-title>Reaction of rhabditis oxycerca after long-term exposure to aldicarb and oxamyl. Ii: Enzyme changes in nematicide resistance</article-title>
<source>Nematologica</source>
<year>1987</year>
<volume>33</volume>
<fpage>298</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="doi">10.1163/187529287X00425</pub-id>
</element-citation></ref><ref id="B83-pathogens-05-00059"><label>83.</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Glazer</surname><given-names>I.</given-names></name><name><surname>Salame</surname><given-names>L.</given-names></name><name><surname>Segal</surname><given-names>D.</given-names></name></person-group>
<article-title>Genetic enhancement of nematicide resistance in entomopathogenic nematodes</article-title>
<source>Biocontrol Sci. Technol.</source>
<year>1997</year>
<volume>7</volume>
<fpage>499</fpage>
<lpage>512</lpage>
<pub-id pub-id-type="doi">10.1080/09583159730578</pub-id>
</element-citation></ref></ref-list></back><floats-group><table-wrap id="pathogens-05-00059-t001" position="float"><object-id pub-id-type="pii">pathogens-05-00059-t001_Table 1</object-id><label>Table 1</label><caption><p>WHO recommended anthelminthic drugs to treat strongyloidiasis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">#</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Drug Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Class (Drench Group)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mode of Action *</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Resistance of Gastrointestinal Nematodes (Veterinary Studies)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Resistance of <italic>Strongyloides</italic> spp. (Veterinary Studies)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1a</td><td align="center" valign="middle" rowspan="1" colspan="1">Albendazole</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Benzimidazole, BZ, &#x0201c;white&#x0201d; (introduced in 1961)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Interaction with &#x003b2;-tubulin impairing cytoskeleton</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1. Horse (97.7%) [<xref rid="B28-pathogens-05-00059" ref-type="bibr">28</xref>]<break/> 2. Sheep (71%) [<xref rid="B29-pathogens-05-00059" ref-type="bibr">29</xref>]</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1. Sheep (57%)[<xref rid="B29-pathogens-05-00059" ref-type="bibr">29</xref>], Sheep (66.7%)[<xref rid="B30-pathogens-05-00059" ref-type="bibr">30</xref>]<break/> 2. Horse [<xref rid="B31-pathogens-05-00059" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1b </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mebendazole</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ivermectin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Macrocyclic lactone, ML, &#x0201c;ectin&#x0201d; (introduced in 1980s)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paralysis of pharyngeal and body wall musculature</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1. Sheep (29%) [<xref rid="B29-pathogens-05-00059" ref-type="bibr">29</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1. Sheep (43%) [<xref rid="B29-pathogens-05-00059" ref-type="bibr">29</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>* Source: [<xref rid="B32-pathogens-05-00059" ref-type="bibr">32</xref>].</p></fn></table-wrap-foot></table-wrap><table-wrap id="pathogens-05-00059-t002" position="float"><object-id pub-id-type="pii">pathogens-05-00059-t002_Table 2</object-id><label>Table 2</label><caption><p>Registered in Australia nematicides and their active constituents.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">#</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Active constituent</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical group</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No. of registered nematicides</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mode of action</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">Fenamiphos</td><td align="center" valign="middle" rowspan="1" colspan="1">Organophosphorus </td><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Inhibition of cholinesterase</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">Oxamyl</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Carbamate-methylcarbamate</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carbofuran </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fluensulfone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thiazole </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table></table-wrap></floats-group></article>